Genome-wide expression profiling during protection from colitis by regulatory T cells

Inflammatory Bowel Diseases

Volumn 14, Issue 1, 2008, Pages 75-87

  Kristensen, Nanna Ny ^a   Olsen, Jørgen ^a   Gad, Monika ^a   Claesson, Mogens Helweg ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Colitis; Gene profiling; Inflammation; Regulatory T cells

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR3; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROTECTION; CELL TRANSFER; COLITIS; CONTROLLED STUDY; DATA ANALYSIS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; IMMUNITY; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECTUM; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA TRANSCRIPTION; SCID MOUSE;

ANIMALS; COLITIS; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; MICE, SCID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CHEMOKINE; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION FACTORS;

EID: 38849089363     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20277     Document Type: Article

References (68)

1. Sartor RB. Review article: role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther. 1997;11(Suppl 3):17-22.
2. Strober W, Fuss IJ, Blumberg RS. The immunology of mucosal models of inflammation. Annu Rev Immunol. 2002;20:495-549.
3. Morrissey PJ, Charrier K, Braddy S, et al. CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells. J Exp Med. 1993;178:237-244.
4. Powrie F, Leach MW, Mauze S, et al. Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993;5:1461-1471.
5. Claesson MH, Rudolphi A, Kofoed S, et al. CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol. 1996;104:491-500.
6. Claesson MH, Bregenholt S, Bonhagen K, et al. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol. 1999;162:3702-3710.
7. Suri-Payer E, Cantor H. Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J Autoimmun. 2001;16:115-123.
8. Kweon MN, Takahashi I, Yamamoto M, et al. Development of antigen induced colitis in SCID mice reconstituted with spleen derived memory type CD4+ CD45RB+ T cells. Gut. 2002;50:299-306.
9. Powrie F, Correa-Oliveira R, Mauze S, et al. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med. 1994;179:589-600.
10. Read S, Malmstrom V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295-302.
11. Lehmann J, Huehn J, de la Rosa M, et al. Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as. Proc Natl Acad Sci USA. 2002;99:13031-13036.
12. Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, et al. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol. 2001;166:3008-3018.
13. Gad M, Kristensen NN, Kury E, et al. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo. Immunology. 2004;113:499-508.
14. Kristensen NN, Brudzewsky D, Gad M, et al. Chemokines involved in protection from colitis by CD4+CD25+ regulatory T cells. Inflamm Bowel Dis. 2006;12:612-618.
15. Mottet C, Uhlig HH, Powrie F. Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol. 2003;170:3939-3943.
16. Asseman C, Mauze S, Leach MW, et al. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190:995-1004.
17. Cottrez F, Groux H. Regulation of TGF-beta response during T cell activation is modulated by IL-10. J Immunol. 2001;167:773-778.
18. Nakamura K, Kitani A, Fuss I, et al. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J Immunol. 2004;172:834-842.
19. Coombes JL, Robinson NJ, Maloy KJ, et al. Regulatory T cells and intestinal homeostasis. Immunol Rev. 2005;204:184-194.
20. Moller PL, Paerregaard A, Gad M, et al. Colitic scid mice fed Lactobacillus spp. show an ameliorated gut histopathology and an altered cytokine profile by local T cells. Inflamm Bowel Dis. 2005;11:814-819.
21. Wang X, Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res. 2003:31:e154.
22. Hansen MB, Skov L, Menne T, et al. Gene transcripts as potential diagnostic markers for allergic contact dermatitis. Contact Dermat. 2005;53:100-106.
23. Csillag C, Nielsen OH, Vainer B, et al. Expression of the genes dual oxidase 2, lipocalin 2 and regenerating islet-derived 1 alpha in Crohn's disease. Scand J Gastroenterol. 2007;42:454-463.
24. Dalgaard P. Introductory Statistics with R. New York: Springer; 2002.
25. Irizarry RA, Bolstad BM, Collin F, et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003;31:e15.
26. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004;5:R80.
27. Zhong S, Storch KF, Lipan O, et al. GoSurfer: a graphical interactive tool for comparative analysis of large gene sets in Gene Ontology space. Appl Bioinform. 2004;3:261-264.
28. Stegmann A, Hansen M, Wang Y, et al. Metabolome, transcriptome, and bioinformatic cis-element analyses point to HNF-4 as a central regulator of gene expression during enterocyte differentiation. Physiol Genomics. 2006;27:141-155.
29. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. Oxford: Blackwell Science; 2002.
30. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci USA. 2003;100:9440-9445.
31. Wold S, Esbensen K, Geladi P. Principal component analysis. Chemomet Intell Lab Syst. 1987;2:37-52.
32. Herv'e A. Partial least squares (PLS) regression. In: Lewis-Beck M. Bryman A, Futing T, eds. Encyclopedia of Social Sciences Research Methods. Thousand Oaks (CA): Sage; 2003.
33. Eriksson L, Antti H, Gottfries J, et al. Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem. 2004;380:419-429.
34. Csillag C, Nielsen OH, Borup R, et al. Clinical phenotype and gene expression profile in Crohn's disease. Am J Physiol Gastrointest Liver Physiol. 2007;292:G298-G304.
35. Pedersen MB, Skov L, Menne T, et al. Gene expression time course in the human skin during elicitation of allergic contact dermatitis. J Invest Dermatol. 2007; (in press).
36. Lee AH, Hong JH, Seo YS. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors. Biochem J. 2000;350(Pt 1):131-138.
37. Wang T, Lafuse WP, Zwilling BS. NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium. J Immunol. 2001;167:6924-6932.
38. Chappell VL, Le LX, LaGrone L, et al. Stat proteins play a role in tumor necrosis factor alpha gene expression. Shock. 2000;14:400-402.
39. Yamanaka S, Zhang XY, Miura K, et al. The human gene encoding the lectin-type oxidized LDL receptor (OLR1) is a novel member of the natural killer gene complex with a unique expression profile. Genomics. 1998;54:191-199.
40. Atreya R, Mudter J, Finotto S, et al. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med. 2000;6:583-588.
41. Lovato P, Brender C, Agnholt J, et al. Constitutive STAT3 activation in intestinal T cells from patients with Crohn's disease. J Biol Chem. 2003;278:16777-16781.
42. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2:998-1004.
43. Ellis RD, Goodlad JR, Limb GA, et al. Activation of nuclear factor kappa B in Crohn's disease. Inflamm Res. 1998;47:440-445.
44. Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001;107:135-142.
45. Ezoe S, Matsumura I, Gale K, et al. GATA transcription factors inhibit cytokine-dependent growth and survival of a hematopoietic cell line through the inhibition of STAT3 activity. J Biol Chem. 2005;280:13163-13170.
46. DeGregori J, Johnson DG. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr Mol Med. 2006;6:739-748.
47. Izcue A, Coombes JL, Powrie F. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev. 2006;212:256-271.
48. Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000;51:289-298.
49. Bamias G, Martin C III, Marini M, et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol. 2003;171:4868-4874.
50. Becker C, Wirtz S, Blessing M, et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest. 2003;112:693-706.
51. Li MC, He SH. IL-10 and its related cytokines for treatment of inflammatory bowel disease. World J Gastroenterol. 2004;10:620-625.
52. O'Sullivan BJ, Thomas HE, Pai S, et al. IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol. 2006;176:7278-7287.
53. Boone DL, Lee EG, Libby S, et al. Recent advances in understanding NF-kappaB regulation. Inflamm Bowel Dis. 2002;8:201-212.
54. Kristensen NN, Gad M, Thomsen AR, et al. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+. Inflamm Bowel Dis. 2006;12:374-381.
55. Bagaeva LV, Rao P, Powers JM, et al. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol. 2006;176:7676-7685.
56. Bregenholt S, Claesson MH. Splenic T helper cell type 1 cytokine profile and extramedullary haematopoiesis in severe combined immunodeficient (scid) mice with inflammatory bowel disease (IBD). Clin Exp Immunol. 1998;111:166-172.
57. Schmidt PT, Hartmann B, Bregenholt S, et al. Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+ T cells. Scand J Gastroenterol. 2000;35:522-527.
58. Liu H, Hu B, Xu D, et al. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol. 2003;171:5012-5017.
59. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179-189.
60. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441:235-238.
61. Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature. 2006;441:231-234.
62. Babyatsky MW, Rossiter G, Podolsky DK. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology. 1996;110:975-984.
63. Sturm A, Schulte C, Schatton R, et al. Transforming growth factor-beta and hepatocyte growth factor plasma levels in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2000;12:445-450.
64. Campbell AP, Smithson J, Lewis C, et al. Altered expression of TGF alpha and TGF beta 1 in the mucosa of the functioning pelvic ileal pouch. J Pathol. 1996;180:407-414.
65. Chen Y, Inobe J, Marks R, et al. Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature. 1995;376:177-180.
66. Lee HO, Miller SD, Hurst SD, et al. Interferon gamma induction during oral tolerance reduces T-cell migration to sites of inflammation. Gastroenterology. 2000;119:129-138.
67. O'Neil D, Steidler L. Cytokines, chemokines and growth factors in the pathogenesis and treatment of inflammatory bowel disease. Adv Exp Med Biol. 2003;520:252-285.
68. Pruitt KD, Tatusova T, Maglott DR. NCBI Reference Sequence (Ref-Seq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2005;33:D501-D504.